Amazon is stripping away job titles at its Ring and Blink security divisions, replacing traditional roles like “Senior” and “Lead” with the single designation “Builder” — a move that signals CEO Andy Jassy’s push to slash bureaucracy just days before the company reports first-quarter earnings. Hundreds of product employees will see their titles vanish during ongoing performance reviews, with managers rebranded as “Builder Leaders.” Salaries and status remain unaffected, but some staff worry the flattened hierarchy muddies promotion paths.
The restructuring comes as Amazon’s healthcare offensive gathers pace. The company’s One Medical primary care service now offers a weight-management program that treats obesity as a chronic condition, bundling doctor consultations, monitoring, and GLP-1 medications through Amazon Pharmacy. Those drugs are already available in nearly 3,000 cities, with plans to expand coverage to 4,500 locations by the end of 2026. Prescriptions can be refilled around the clock, with prices starting at $29. The integrated model lets clinicians manage weight loss alongside related conditions like diabetes and cardiovascular disease, creating a recurring revenue stream from both prescriptions and deliveries.
The healthcare push is part of a broader strategy that also includes Amazon’s generative AI assistant Alexa+, which launched in Spain on April 23 with localized language and cultural features. But the real focus for investors is the earnings report due Wednesday, April 29. Analysts expect first-quarter profit of roughly $1.61 to $1.62 per share on revenue between $177 billion and $178 billion.
Amazon’s stock trades around €219, just shy of its 52-week high, having gained about 34% over the past twelve months. The consensus analyst rating remains “Buy.” Several banks have raised price targets: UBS lifted its to $304, citing AWS revenue growth of 38% in 2026 — well above the consensus estimate of 26%. BMO Capital sees a target of $315, while Cantor Fitzgerald set its at $280. Both point to rising demand from AI labs and improvements in the supply chain.
Should investors sell immediately? Or is it worth buying Amazon?
The cloud division’s first-quarter revenue consensus stands at roughly $36.8 billion, with margins expected at 35.7% — down from 37.7% in October. That margin compression reflects Amazon’s massive capital expenditure program, which has nearly quadrupled to about $200 billion for 2026 compared to 2023 levels. The bulk of that spending goes to AI data centers, the Project Kuiper satellite service, and the Trainium 3 AI training chip, all aimed at positioning AWS as the backbone of the global AI economy.
UBS’s optimism is partly fueled by Amazon’s recent partnerships with OpenAI and Anthropic, which together could add roughly $200 billion to AWS’s order backlog — a figure that helps justify the eye-popping investment outlay. The earnings report will test whether those deals are translating into real revenue, and the second-quarter guidance may draw even more scrutiny than the first-quarter numbers themselves.
The “Builder” title change at Ring and Blink, meanwhile, echoes a broader Silicon Valley trend. Meta is experimenting with a similar model under the “AI Builder” label, reflecting an industry shift toward employees who use AI tools to accomplish tasks that once required entire teams. For Amazon, the cultural overhaul and the healthcare expansion are two fronts in a single campaign: proving that the company can innovate beyond e-commerce and cloud computing, while keeping Wall Street convinced that the $200 billion bet on AI infrastructure will pay off.
Ad
Amazon Stock: Buy or Sell?! New Amazon Analysis from April 24 delivers the answer:
The latest Amazon figures speak for themselves: Urgent action needed for Amazon investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from April 24.
Amazon: Buy or sell? Read more here...
